8.28
price down icon6.02%   -0.53
after-market Handel nachbörslich: 8.28
loading

Finanzdaten der Scilex Holding Company-Aktie (SCLX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
10.56
- 5.004 14.90 14.44
Cost Of Revenue
3.329
- 1.384 4.691 3.768
Gross Profit
7.231
- 3.62 10.21 10.67
Operating Expenses
193.74
- 31.52 38.59 30.59
Benefits Costs and Expenses
268.38
- 31.08 21.36 18.82
Costs And Expenses
268.38
- 31.08 21.36 18.82
Operating Income/Loss
-186.51
- -27.90 -28.38 -19.92
Nonoperating Income/Loss
-71.31
- 1.818 21.92 15.53
Income/Loss From Continuing Operations Before Tax
485.31%
-257.82
-44.05 -26.08 -6.461 -4.388
Income Tax Expense/Benefit
0.001
- - -0.001 -
Income/Loss From Continuing Operations After Tax
485.32%
-257.82
-44.05 -26.08 -6.46 -4.388
Net Income/Loss
485.32%
-257.82
-44.05 -26.08 -6.46 -4.388
Preferred Stock Dividends And Other Adjustments
-0.586
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.0116
- 0.0116 131.02 0.127
Diluted Average Shares
0.0116
- 0.0116 133.96 0.127
Basic Earnings Per Share
-22.17
- -2.26 - -0.03
Diluted Earnings Per Share
-22.17
- -2.26 -0.05 -0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-0.586
- - - -
drug_manufacturers_general PFE
$26.58
price down icon 1.04%
drug_manufacturers_general NVO
$37.96
price down icon 0.16%
$144.99
price down icon 0.15%
$366.21
price down icon 0.43%
drug_manufacturers_general MRK
$115.61
price down icon 0.26%
drug_manufacturers_general NVS
$153.44
price down icon 0.53%
Kapitalisierung:     |  Volumen (24h):